T cell response to tumor antigens and its therapeutic use in cancer patients

Giorgio Parmiani; Chiara Castelli; Piero Dalerba; Licia Rivoltini

doi:10.1007/978-1-4615-0685-0_59

T cell response to tumor antigens and its therapeutic use in cancer patients

Giorgio Parmiani
, Chiara Castelli
, Piero Dalerba
, Licia Rivoltini

Center for Discovery and Innovation

IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	403-410
Number of pages	8
Journal	Advances in Experimental Medicine and Biology
Volume	495
DOIs	https://doi.org/10.1007/978-1-4615-0685-0_59
State	Published - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/978-1-4615-0685-0_59

Cite this

@article{0a8a80aa5b614e388a3163c7850a78d1,

title = "T cell response to tumor antigens and its therapeutic use in cancer patients",

author = "Giorgio Parmiani and Chiara Castelli and Piero Dalerba and Licia Rivoltini",

year = "2001",

doi = "10.1007/978-1-4615-0685-0\_59",

language = "English",

volume = "495",

pages = "403--410",

journal = "Advances in Experimental Medicine and Biology",

issn = "0065-2598",

publisher = "Springer",

}

TY - JOUR

T1 - T cell response to tumor antigens and its therapeutic use in cancer patients

AU - Parmiani, Giorgio

AU - Castelli, Chiara

AU - Dalerba, Piero

AU - Rivoltini, Licia

PY - 2001

Y1 - 2001

UR - https://www.scopus.com/pages/publications/0035699852

U2 - 10.1007/978-1-4615-0685-0_59

DO - 10.1007/978-1-4615-0685-0_59

M3 - Article

C2 - 11774601

AN - SCOPUS:0035699852

SN - 0065-2598

VL - 495

SP - 403

EP - 410

JO - Advances in Experimental Medicine and Biology

JF - Advances in Experimental Medicine and Biology

ER -

T cell response to tumor antigens and its therapeutic use in cancer patients

UN SDGs

Access to Document

Other files and links

Cite this